Lessee, Operating Lease, Liability, to be Paid, Year One in USD of C4 Therapeutics, Inc. from Q3 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
C4 Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and change rate from Q3 2020 to Q4 2024.
  • C4 Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending December 31, 2024 was $9.09M, a 3% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)

C4 Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $9.09M +$265K +3% Dec 31, 2024 10-K 2025-02-27
Q4 2023 $8.83M +$257K +3% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $8.57M +$5.58M +186% Dec 31, 2022 10-K 2023-02-23
Q3 2022 $8.57M +$6.23M +266% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $8.57M +$6.23M +266% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $8.57M +$6.23M +266% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $2.99M +$722K +31.8% Dec 31, 2021 10-K 2022-02-24
Q3 2021 $2.34M +$68K +2.99% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $2.34M Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $2.34M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $2.27M Dec 31, 2020 10-K 2021-03-11
Q3 2020 $2.27M Sep 30, 2020 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.